MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$129.56
Tradestie Score
62
Market Cap
$225.13B
P/E Ratio
35.3
Revenue Growth
0.0%
Analyst Upside
+0.9%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$263.04
|
$448.07B | 29.4 | 65 | Compare |
|
ABBV
ABBVIE INC.
|
$261.07
|
$431.71B | 123.7 | 60 | Compare |
|
PG
Procter & Gamble Company
|
$151.41
|
$358.52B | 21.6 | 59 | Compare |
|
NVO
Novo-Nordisk A/S
|
$50.43
|
$262.92B | 11.7 | 58 | Compare |
|
AZN
AstraZeneca PLC
|
$195.15
|
$261.56B | 29.2 | 62 | Compare |
|
NVS
Novartis AG
|
$159.90
|
$254.99B | 22.1 | 59 | Compare |
|
VZ
Verizon Communications
|
$42.56
|
$184.80B | 10.2 | 59 | Compare |
|
AMGN
Amgen Inc
|
$374.15
|
$160.70B | 25.1 | 69 | Compare |
|
PFE
Pfizer Inc.
|
$24.32
|
$154.70B | 18.2 | 60 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.27
|
$137.92B | 17.2 | 67 | Compare |
More MRK Analysis
Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry